06-08-2024 |
PM |
|
BEAM |
Beam Therapeutics |
2,258 |
-1.11 |
-1.13 |
0.00 |
Beam Therapeutics GAAP EPS of -$1.11 beats by $0.01, revenue of $11.77M misses by $1.28M [8/6/2024 6:41 AM] |
25.49 |
-0.12 (-0.47%) |
25.16 |
-0.45 (-1.76%) |
16.95 - 49.50 |
1,038,117 |
1,470,000 |
2,244 |
|
|
07-05-2024 |
PM |
|
BEAM |
Beam Therapeutics |
1,904 |
-1.21 |
-1.45 |
0.00 |
Beam Therapeutics GAAP EPS of -$1.21 beats by $0.23, revenue of $7.41M misses by $7.25M [5/7/2024 6:35 AM] |
22.52 |
-0.27 (-1.16%) |
22.99 |
0.21 (0.92%) |
16.95 - 49.50 |
755,325 |
1,260,000 |
8,566 |
|
|
08-11-2023 |
PM |
|
BEAM |
Beam Therapeutics |
1,845 |
-1.22 |
-1.37 |
0.00 |
Beam Therapeutics GAAP EPS of -$1.22 beats by $0.03, revenue of $17.19M misses by $6.7M [11/8/2023 6:46 AM] |
22.91 |
-2.08 (-8.32%) |
25.29 |
0.30 (1.20%) |
16.95 - 54.30 |
1,667,162 |
1,730,000 |
1,279 |
|
|
10-05-2023 |
PM |
6:30 AM ET (May 10) |
BEAM |
Beam Therapeutics |
2,490 |
-1.33 |
-1.36 |
0.00 |
Beam Therapeutics GAAP EPS of -$1.33 in-line, revenue of $24.2M beats by $8.56M [5/10/2023 8:47 AM] |
35.94 |
1.43 (4.14%) |
34.97 |
0.46 (1.33%) |
27.77 - 73.27 |
922,863 |
800,000 |
3,612 |
|
|
28-02-2023 |
PM |
|
BEAM |
Beam Therapeutics Inc. |
2,880 |
-0.54 |
-1.32 |
-0.85 |
Beam Therapeutics GAAP EPS of -$0.54 beats by $0.81, revenue of $20.04M beats by $7.31M [2/28/2023 6:59 AM] |
40.41 |
1.42 (3.64%) |
39.60 |
0.61 (1.56%) |
27.77 - 80.00 |
949,894 |
770,000 |
1,233 |
|
|
07-11-2022 |
PM |
6:30 AM ET (Nov 7) |
BEAM |
Beam Therapeutics |
3,096 |
-1.56 |
-1.30 |
0.00 |
Beam Therapeutics GAAP EPS of -$1.56 misses by $0.26, revenue of $15.79M beats by $8.64M [11/7/2022 6:50 AM] |
37.90 |
-4.90 (-11.46%) |
39.07 |
-3.73 (-8.71%) |
27.77 - 100.06 |
1,662,465 |
850,000 |
9,578 |
|
|
09-05-2022 |
PM |
|
BEAM |
Beam Therapeutics |
2,598 |
-1.01 |
-1.10 |
0.00 |
Beam Therapeutics GAAP EPS of -$1.01 misses by $0.12, revenue of $8.43M [5/9/2022 6:47 AM] |
33.19 |
-2.49 (-6.98%) |
34.26 |
-1.42 (-3.98%) |
32.90 - 138.52 |
1,567,393 |
1,240,000 |
1,885 |
|
|
28-02-2022 |
PM |
6:00 AM ET (Feb 28) |
BEAM |
Beam Therapeutics |
4,794 |
-0.85 |
-1.02 |
0.00 |
Beam Therapeutics GAAP EPS of -$0.95, revenue of $51.07M [2/28/2022 6:51 AM] |
77.66 |
2.91 (3.89%) |
72.05 |
-2.70 (-3.61%) |
56.34 - 138.52 |
626,442 |
830,000 |
8,251 |
|
|
08-11-2021 |
PM |
|
BEAM |
Beam Therapeutics |
6,201 |
-0.42 |
-0.78 |
0.00 |
Beam Therapeutics EPS beats by $0.38, misses on revenue [11/8/2021 6:10 AM] |
99.01 |
9.48 (10.59%) |
94.16 |
4.63 (5.17%) |
33.14 - 138.52 |
685,810 |
430,000 |
4,188 |
|
|
10-08-2021 |
PM |
6:30 AM ET (Aug 10) |
BEAM |
Beam Therapeutics Inc. |
6,783 |
-0.95 |
-0.58 |
0.00 |
Beam Therapeutics EPS misses by $0.60, misses on revenue [8/10/2021 6:42 AM] |
104.28 |
-2.68 (-2.51%) |
104.28 |
0.0 (0.00%) |
21.24 - 138.52 |
738,092 |
660,000 |
179 |
|
|
11-05-2021 |
PM |
6:30 AM ET (May 11) |
BEAM |
Beam Therapeutics Inc. |
4,430 |
-3.35 |
-0.72 |
-1.03 |
Beam Therapeutics EPS misses by $2.61 [5/11/2021 6:38 AM] |
66.23 |
2.11 (3.29%) |
57.30 |
-6.82 (-10.64%) |
16.80 - 126.90 |
2,239,994 |
790,000 |
26,187 |
|
|
15-03-2021 |
PM |
After the close (Mar 15) |
BEAM |
Beam Therapeutics Inc. |
5,487 |
-0.72 |
-0.70 |
0.00 |
Beam Therapeutics reports Q4 results [3/15/2021 6:46 AM] |
94.92 |
-3.50 (-3.56%) |
99.60 |
1.18 (1.20%) |
13.00 - 126.90 |
668,682 |
1,358,265 |
1,221 |
|
|
10-11-2020 |
PM |
|
BEAM |
Beam Therapeutics Inc. |
1,869 |
-0.69 |
-0.57 |
0.00 |
Beam Therapeutics EPS misses by $0.12 [11/10/2020 6:35 AM] |
37.60 |
0.67 (1.81%) |
0.0 |
0.0 (0.00%) |
13.00 - 38.89 |
376,160 |
527,712 |
0 |
|
|
10-11-2020 |
PM |
|
BEAM |
Beam Therapeutics Inc. |
2,040 |
-0.69 |
-0.57 |
0.00 |
Beam Therapeutics EPS misses by $0.12 [11/10/2020 6:35 AM] |
34.39 |
-3.47 (-9.17%) |
37.50 |
-0.36 (-0.95%) |
13.00 - 41.19 |
1,099,141 |
550,920 |
1,176 |
|
|